These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31091786)

  • 1. Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety.
    He R; Finan B; Mayer JP; DiMarchi RD
    Molecules; 2019 May; 24(10):. PubMed ID: 31091786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics.
    Dean TT; Jelú-Reyes J; Allen AC; Moore TW
    J Med Chem; 2024 Feb; 67(3):1641-1661. PubMed ID: 38277480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and challenges of fatty acid conjugated therapeutics.
    Bhat M; Jatyan R; Mittal A; Mahato RI; Chitkara D
    Chem Phys Lipids; 2021 May; 236():105053. PubMed ID: 33484709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Igniting Small-Molecule Drug Discovery.
    Steinhagen H
    ChemMedChem; 2016 Jan; 11(2):148-9. PubMed ID: 26781775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic and structural routes for the rational conversion of peptides into small molecules.
    Scognamiglio PL; Morelli G; Marasco D
    Methods Mol Biol; 2015; 1268():159-93. PubMed ID: 25555725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Ligand-Targeted Drug Conjugates for Cancer Therapy and Their Evaluation In Vitro.
    Krishnan MA; Sengupta S; Chelvam V
    Curr Protoc Chem Biol; 2018 Dec; 10(4):e50. PubMed ID: 30212603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrion-Targeting Peptides and Peptidomimetics: Recent Progress and Design Principles.
    Kim S; Nam HY; Lee J; Seo J
    Biochemistry; 2020 Jan; 59(3):270-284. PubMed ID: 31696703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule mimics of DFTamP1, a database designed anti-Staphylococcal peptide.
    Dong Y; Lushnikova T; Golla RM; Wang X; Wang G
    Bioorg Med Chem; 2017 Feb; 25(3):864-869. PubMed ID: 28011203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small targeted cytotoxics from DNA-encoded chemical libraries.
    Samain F; Casi G
    Curr Opin Chem Biol; 2015 Jun; 26():72-9. PubMed ID: 25726911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances at the intersection of chemical biology and medicinal chemistry.
    Tavassoli A
    Future Med Chem; 2015; 7(16):2089-90. PubMed ID: 26571116
    [No Abstract]   [Full Text] [Related]  

  • 11. Generalizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule Compounds.
    Lawatscheck C; Pickhardt M; Wieczorek S; Grafmüller A; Mandelkow E; Börner HG
    Angew Chem Int Ed Engl; 2016 Jul; 55(30):8752-6. PubMed ID: 27282127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal α-amino group modification of antibodies using a site-selective click chemistry method.
    Li DZ; Han BN; Wei R; Yao GY; Chen Z; Liu J; Poon TCW; Su W; Zhu Z; Dimitrov DS; Zhao Q
    MAbs; 2018 Jul; 10(5):712-719. PubMed ID: 29652547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery conference 2008. Small-Molecule Drug Discovery: From Early Stage to the Clinic.
    Terrett NK
    IDrugs; 2008 Mar; 11(3):164-8. PubMed ID: 18311648
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.
    Våbenø J; Haug BE; Rosenkilde MM
    Future Med Chem; 2015; 7(10):1261-83. PubMed ID: 26144264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging PEGylated drugs.
    Kang JS; Deluca PP; Lee KC
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):363-80. PubMed ID: 19453284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems Pharmacology in Small Molecular Drug Discovery.
    Zhou W; Wang Y; Lu A; Zhang G
    Int J Mol Sci; 2016 Feb; 17(2):246. PubMed ID: 26901192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-noncompetitive CDK inhibitors for cancer therapy: an overview.
    Abate AA; Pentimalli F; Esposito L; Giordano A
    Expert Opin Investig Drugs; 2013 Jul; 22(7):895-906. PubMed ID: 23735075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of CXC chemokines and their receptors in cancer.
    Vinader V; Afarinkia K
    Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.